Waning immunity and microbial vaccines—workshop of the National Institute of Allergy and Infectious Diseases

XX Gu, SA Plotkin, KM Edwards, A Sette… - Clinical and Vaccine …, 2017 - Am Soc Microbiol
Since the middle of the 20th century, vaccines have made a significant public health impact
by controlling infectious diseases globally. Although long-term protection has been achieved …

The safety of immunizing with tetanus–diphtheria–acellular pertussis vaccine (Tdap) less than 2 years following previous tetanus vaccination: experience during a …

EA Talbot, KH Brown, KB Kirkland, AL Baughman… - Vaccine, 2010 - Elsevier
BACKGROUND: Tdap is recommended for health care personnel (HCP) aged< 65 years
who received tetanus diphtheria or tetanus toxoid immunization (Td/TT)≥ 2 years earlier …

[HTML][HTML] Humoral immunity 10 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular …

V Pool, A Tomovici, DR Johnson, DP Greenberg… - Vaccine, 2018 - Elsevier
Background In a prospective, randomized pivotal phase III clinical trial, the immunogenicity
and reactogenicity of a tetanus-diphtheria-acellular pertussis vaccine (Tdap) and a tetanus …

Randomized controlled trial of the safety and immunogenicity of revaccination with tetanus-diphtheria-acellular pertussis vaccine (Tdap) in adults 10 years after a …

SA Halperin, C Donovan, GS Marshall… - Journal of the …, 2019 - academic.oup.com
Background Reduced-antigen-content tetanus, diphtheria, and acellular pertussis (Tdap)
vaccine is recommended in many countries for boosting immunity in adolescents and adults …

Undervaccination with diphtheria, tetanus, and pertussis vaccine: national trends and association with pertussis risk in young children

WT Huang, HC Lin, CH Yang - Human vaccines & …, 2017 - Taylor & Francis
Background: The high coverage for≥ 3 pertussis vaccine doses among Taiwanese children
might not imply timely vaccination. Recently, resurgence of pertussis and challenges with …

[HTML][HTML] The effectiveness and safety of pertussis booster vaccination for adolescents and adults: A systematic review and meta-analysis

J Xu, S Liu, Q Liu, R Rong, W Tang, Q Wang, S Kuang… - Medicine, 2019 - journals.lww.com
Background: Due to the resurgence of pertussis, many countries have revised the pertussis
immunization schedules and recommended booster doses of pertussis component vaccine …

[HTML][HTML] Waning protection following 5 doses of a 3-component diphtheria, tetanus, and acellular pertussis vaccine

NP Klein, J Bartlett, B Fireman, L Aukes, PO Buck… - Vaccine, 2017 - Elsevier
Background The effectiveness of diphtheria, tetanus, and acellular pertussis (DTaP)
vaccines wanes substantially after the 5 th dose given at ages 4–6 years, but has not been …

Persistence of antibodies 3 years after booster vaccination of adults with combined acellular pertussis, diphtheria and tetanus toxoids vaccine

W Weston, M Messier, LR Friedland, X Wu, B Howe - Vaccine, 2011 - Elsevier
The duration of protection after vaccination with reduced antigen content diphtheria, tetanus
and acellular pertussis vaccines (Tdap) is not known. Long-term post-vaccination …

Immune persistence after pertussis vaccination

Z Chen, Q He - Human vaccines & immunotherapeutics, 2017 - Taylor & Francis
Pertussis is one of the most prevalent vaccine-preventable diseases worldwide. The true
infection rate is significantly higher than the reported incidence rate. An increased …

Pertussis vaccine effectiveness and duration of protection–A systematic review and meta-analysis

K Wilkinson, CH Righolt, LJ Elliott, S Fanella… - Vaccine, 2021 - Elsevier
A comprehensive review of observational pertussis vaccine effectiveness (VE) studies is
needed to update gaps from previous reviews. We conducted a systematic review of VE and …